The sensitivity of substance abuse treatment intensity to co-payment levels

Journal of Behavioral Health Services and Research

Volumn 31, Issue 1, 2004, Pages 50-65

  Lo Sasso, Anthony T ^a   Lyons, John S ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABUSE; ARTICLE; DRUG DEPENDENCE; FEMALE; HEALTH BEHAVIOR; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MENTAL HEALTH SERVICE; MULTIPLE REGRESSION; OUTPATIENT; RISK BENEFIT ANALYSIS; SENSITIVITY ANALYSIS; SUBSTANCE ABUSE; ADDICTION; COMORBIDITY; COMPARATIVE STUDY; COST; COST OF ILLNESS; DRUG DEPENDENCE TREATMENT; ECONOMICS; HEALTH INSURANCE; PATIENT CARE; STATISTICAL MODEL; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADULT; CHICAGO; COMORBIDITY; COST OF ILLNESS; COST SHARING; EPISODE OF CARE; FEMALE; HEALTH BENEFIT PLANS, EMPLOYEE; HUMANS; MALE; MANAGED CARE PROGRAMS; MODELS, ECONOMETRIC; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 1442279512     PISSN: 10943412     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02287338     Document Type: Article

References (48)

1. Chaloupka F. Rational addictive behavior and cigarette smoking. Journal of Political Economy. 1991;99:722-742.
2. Becker GS, Grossman M, Murphy KM. An empirical analysis of cigarette addiction. American Economic Review. 1994;84:396-418.
3. Pacula RL. Does increasing the beer tax reduce mari juana consumption? Journal of Health Economics. 1998:17(5):557-585.
4. Manning WG, Blumberg L, Moulton LH. The demand for alcohol: the differential response to price. Journal of Health Economics. 1995;14:123-148.
5. Grossman M, Chaloupka FJ, Sirtalan I. An empirical analysis of alcohol addiction: results from the monitoring the future panels. Economic Inquiry. 1998;36:39-48.
6. Chaloupka FJ, Grossman M, Taurus JA. The demand for cocaine and marijuana by youth. In: Chaloupka FJ, Grossman M, Biclal WK, Saffen H, eds. The Economic Analysis of Substance Use and Abuse: An Integration of Econometric and Behavioral Economic Research. Chicago: University of Chicago Press; 1999:133-155.
7. Saffer H, Chaloupka FJ. The demand for illicit drugs. Economic Inquiry. 1999;37(3):401-411.
8. Farrelly MC, Bray JW, Zarkin GA, et al. The joint demand for cigarettes and marijuana: evidence from the National Household Surveys on Drug Abuse. Journal of Health Economics. 2001;20(1):51-68.
9. Zweifel P, Manning WG. Moral hazard and consumer incentives in health care. In: Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Amsterdam: Elsevier; 2000.
10. McLellan AT, Woody GE, Metzger D, et al. Evaluating the effectiveness of addiction treatment: reasonable expectations, appropriate comparisons. In: Egerton JA, Fox DM, Leshner Al, eds. Treating Drug Abusers' Effectively. Malden, Mass: Blackwell; 1997.
11. Bell DC, Richard AJ, Feltz LC. Mediators of drug treatment outcomes. Addictive Behaviors. 1996;21(5):597-613.
12. Ershoff D, Radcliffe A, Gregory M. The southern California Kaiser-Permanente chemical dependency recovery program evaluation: results of a treatment outcome study in an HMO setting. Journal of Addictive Diseases. 1996;15(3):1-25.
13. Hoffmann NG, Miller NS. Treatment outcomes for abstinence-based programs. Psychiatric Annals. 1992:22(8):402-408.
14. Hubbard RL, Marsden ME, Rachal JV. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC: University of North Carolina Press; 1989.
15. McKay JR, Alterman Al, McLellan AT, et al. Treatment goals, continuity of care and outcomes in a day hospital substance abuse rehabilitation program. American Journal of Psychiatry. 1994:151(2):254-259.
16. Moos RH, Finney JW, Cronkite RC. Alcoholism Treatment: Content, Process, and Outcome. New York: Oxford University Press; 1990.
17. Simpson DD. Effectiveness of drug-abuse treatment: a review of research from field settings. In: Egerton JA, Fox DM, Leshner Al, eds. Treating Drug Abuse Effectively. Malden, Mass: Blackwell; 1997.
18. Hoffman JA, Caudill BD, Koman JJ III, et al. Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure. Journal of Addictive Diseases. 1994;13(4):115-128.
19. French MT, Mauskopf JA, Teague JL, et al. Estimating the dollar value of health outcomes from drug-abuse interventions. Medical Care. 1996;34:890-910.
20. Newhouse JP, and the Insurance Experiment Group. Free for All? Lessons from the RAND Health Insurance Experiment. Cambridge, Mass: Harvard University Press; 1994.
21. Manning WG, Newhouse JP, Duan N, et al. Health insurance and the demand for medical care: evidence from a randomized experiment. American Economic Review. 1987;77:251-277.
22. Manning WG, Wells KB, Duan N, et al. How cost sharing affects the use of ambulatory mental health services. Journal of the American Medical Association. 1986;256:1930-1934.
23. Keeler EB, Manning WG, Wells KB. The demand for episodes of mental health services. Journal of Health Economics. 1988;7:369-392.
24. Frank RG, McGuire TG. Economics and mental health. In: Culyer AJ, Newhouse JP, eds. Handbook of Health Economics. Amsterdam: Elsevier; 2000.
25. Findlay S. Managed behavioral health care in 1999: an industry at a crossroads. Health Affairs. 1999;18:116-124.
26. Sturm R, Zhang W, Schoenbaum M. How expensive are unlimited substance abuse benefits under managed care? The Journal of Behavioral Health Services & Research. 1999;26(2):203-210.
27. Strurm R. Managed care risk contracts and substance abuse treatment. Inquiry. 2000;37:219-225.
28. Lave JR, Peele PB, Xu Y, et al. An exploratory analysis of behavioral health care use within families. Psychiatric Services. 2002;53:743-748.
29. Alexander JA, Lemak CH. The effects of managed care on administrative burden in outpatient substance abuse treatment facilities. Medical Care. 1997;35(10):1060-1068.
30. Alexander JA, Wheeler JRC, Nahra T, et al. Managed care and technical efficiency in outpatient substance abuse treatment units. Journal of Behavioral Health Services & Research. 1998;25(4):377-396.
31. Liu X, Sturm R, Cuffel BJ. The impact of prior authorization on outpatient utilization in managed behavioral health plans. Medical Research and Review. 2000;57(2):182-195.
32. Lemak CH, Alexander JA. Managed care and outpatient substance abuse treatment intensity. Journal of Behavioral Health Services & Research. 2001;28(1):12-29.
33. Lo Sasso AT, Lyons JS. The effects of copayments on substance abuse treatment expenditures and treatment reoccurrence. Psychiatric Services. 2002;53(12):1605-1611.
34. Stein B, Orlando M, Sturm R. The effect of copayments on drug and alcohol treatment following inpatient detoxification under managed care. Psychiatric Services. 2000;51(2):195-198.
35. Frank RG, Goldman MM, McGuire TG. A model mental health benefit in private health insurance. Health Affairs. 1992;11:98-117.
36. Frank RG, McGuire TG, Newhouse JP. Risk contracts in managed mental health care. Health Affairs. 1995;14:50-64.
37. Frank RG, Huskamp HA, McGuire TG, et al. Some economics of mental health "carve-outs". Archives of General Psychiatry. 1996;53:933-937.
38. Dowd CE, Ashley-Dixon R. Consolidation: the changing face of the behavioral healthcare industry. Managed Care Quarterly. 1999;7(1):61-63.
39. Greenberg W, Allen J, Wider JJ, et al. Industry consolidation: what's at stake for consumers and purchasers? Behavioral Healthcare Tomorrow. 1998;7(4):32-38.
40. Keeler EB, Rolph JE. The demand for episodes of treatment in the health insurance experiment. Journal of Health Economics. 1988;7:337-367.
41. Huskamp HA. Episodes of mental health and substance abuse treatment under a managed behavioral health care carve-out. Inquiry. 1999;36:147-161.
42. Simon GE, Fishman P. Cost implications of initial antidepressant selection in primary care. Pharmacoeconomics. 1998;13(1, pt 1):61-70.
43. Kessler LG, Steinwachs DM, Hankin JR. Episodes of psychiatric care and medical utilization. Medical Care. 1980;8:1219-1227.
44. Greene WH. Econometric Analysis. 4th ed. Upper Saddle River, NJ: Prentice-Hall; 2000.
45. Ferguson FN. Stake theory as an explanatory device in Navajo alcoholism treatment response. Human Organization. 1976;35(1):65-78.
46. Hubbard RL, Marsden ME, Rachal JV, et al. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC: University of North Carolina Press; 1989.
47. Goodman AC, Holder HD, Nishiura E. Alcoholism treatment offset effects: a cost model. Inquiry. 1991;28(2):168-178.
48. Holder HD, Blose JO. Alcoholism treatment and total health care utilization andcosts: a four-year longitudinal analysis of federal employees. Journal of the American Medical Association. 1986;256:1456-1460.